{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:44:03Z","timestamp":1784807043409,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFC1310600"],"award-info":[{"award-number":["2017YFC1310600"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970112"],"award-info":[{"award-number":["31970112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Projects of Major Infectious Disease Control and Prevention","award":["2017ZX10103011"],"award-info":[{"award-number":["2017ZX10103011"]}]},{"name":"Open Projects Program of Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment","award":["2017B030314152"],"award-info":[{"award-number":["2017B030314152"]}]},{"DOI":"10.13039\/501100009330","name":"Science and Technology Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2019A1515011395"],"award-info":[{"award-number":["2019A1515011395"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.phrs.2020.105095","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T21:58:23Z","timestamp":1595887103000},"page":"105095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD"],"prefix":"10.1016","volume":"160","author":[{"given":"Haiyue","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daowen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongchang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2020.105095_bib0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1183\/09031936.06.00025805","article-title":"Chronic obstructive pulmonary disease: current burden and future projections","volume":"27","author":"Lopez","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2020.105095_bib0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1513\/pats.200605-105SF","article-title":"Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease?","volume":"3","author":"Taraseviciene-Stewart","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.phrs.2020.105095_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/resp.12660","article-title":"Global burden of COPD","volume":"21","author":"Lopez-Campos","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.phrs.2020.105095_bib0020","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/S0140-6736(01)07097-0","article-title":"Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial","volume":"358","author":"Nouira","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2020.105095_bib0025","article-title":"Antibiotics for exacerbations of chronic obstructive pulmonary disease","volume":"12","author":"Vollenweider","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2020.105095_bib0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1164\/rccm.200906-0837OC","article-title":"Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","volume":"181","author":"Daniels","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2020.105095_bib0035","series-title":"Pocket Guide to COPD Diagnosis, Management and Prevention. A Guide for Health Care Professionals","author":"Global initiative for chronic obstructive lung disease (GOLD)","year":"2019"},{"key":"10.1016\/j.phrs.2020.105095_bib0040","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1164\/rccm.201302-0289PP","article-title":"Antibiotics for acute and chronic respiratory infection in patients with chronic obstructive pulmonary disease","volume":"188","author":"Miravitlles","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2020.105095_bib0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2042098614554919","article-title":"Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem","volume":"5","author":"Llor","year":"2014","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.phrs.2020.105095_bib0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/COPD.S1089","article-title":"Optimizing antibiotic selection in treating COPD exacerbations","volume":"3","author":"Siddiqi","year":"2008","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.phrs.2020.105095_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047305","article-title":"The lung microbiome in moderate and severe chronic obstructive pulmonary disease","volume":"7","author":"Pragman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2020.105095_bib0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/thoraxjnl-2015-207235","article-title":"Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers","volume":"71","author":"Einarsson","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.phrs.2020.105095_bib0065","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/JCM.00035-14","article-title":"Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease","volume":"52","author":"Huang","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.phrs.2020.105095_bib0070","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1183\/13993003.01406-2015","article-title":"Lung microbiome dynamics in COPD exacerbations","volume":"47","author":"Wang","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.phrs.2020.105095_bib0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/thoraxjnl-2017-210741","article-title":"Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study","volume":"73","author":"Wang","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.phrs.2020.105095_bib0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/thoraxjnl-2017-210408","article-title":"Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations","volume":"73","author":"Mayhew","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.phrs.2020.105095_bib0085","article-title":"Sputum microbiome is associated with 1-year mortality following COPD hospitalizations","author":"Leitao Filho","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2020.105095_bib0090","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/thoraxjnl-2015-207194","article-title":"Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial","volume":"70","author":"Brill","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.phrs.2020.105095_bib0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.phrs.2020.105095_bib0100","doi-asserted-by":"crossref","first-page":"398S","DOI":"10.1378\/chest.117.5_suppl_2.398S","article-title":"Toward a consensus definition for COPD exacerbations","volume":"117","author":"Rodriguez-Roisin","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2020.105095_bib0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/QCO.0000000000000533","article-title":"Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones?","volume":"32","author":"Jacobs","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.phrs.2020.105095_bib0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13059-015-0637-x","article-title":"Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease","volume":"16","author":"Morgan","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.phrs.2020.105095_bib0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000330667","article-title":"Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease","volume":"83","author":"Bafadhel","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.phrs.2020.105095_bib0120","first-page":"339","article-title":"Microscopic and baceriologic analysis of expectorated sputum","volume":"50","author":"Murray","year":"1975","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.phrs.2020.105095_bib0125","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/318151","article-title":"Prospective study of the usefulness of sputum gram stain in the initial approach to community-acquired pneumonia requiring hospitalization","volume":"31","author":"Roson","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.phrs.2020.105095_bib0130","first-page":"166","article-title":"Microbiological processing of respiratory specimens from patients with cystic fibrosis","volume":"4","author":"Recommendations of the Clinical Subcommittee of the Medical\/Scientific Advisory Committee of the Canadian Cystic Fibrosis F","year":"1993","journal-title":"Can. J. Infect. Dis."},{"key":"10.1016\/j.phrs.2020.105095_bib0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12915-014-0087-z","article-title":"Reagent and laboratory contamination can critically impact sequence-based microbiome analyses","volume":"12","author":"Salter","year":"2014","journal-title":"BMC Biol."},{"key":"10.1016\/j.phrs.2020.105095_bib0140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.phrs.2020.105095_bib0145","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ismej.2010.160","article-title":"Zou F: BIPES, a cost-effective high-throughput method for assessing microbial diversity","volume":"5","author":"Zhou","year":"2011","journal-title":"ISME J."},{"key":"10.1016\/j.phrs.2020.105095_bib0150","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","article-title":"UCHIME improves sensitivity and speed of chimera detection","volume":"27","author":"Edgar","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.phrs.2020.105095_bib0155","doi-asserted-by":"crossref","DOI":"10.3402\/jom.v7.28934","article-title":"Robust species taxonomy assignment algorithm for 16S rRNA NGS reads: application to oral carcinoma samples","volume":"7","author":"Al-Hebshi","year":"2015","journal-title":"J. Oral Microbiol."},{"key":"10.1016\/j.phrs.2020.105095_bib0160","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1128\/AEM.00062-07","article-title":"Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy","volume":"73","author":"Wang","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.phrs.2020.105095_bib0165","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.phrs.2020.105095_bib0170","series-title":"The WEKA Workbench. Online Appendix for \u201cData Mining: Practical Machine Learning Tools and Techniques\u201d","author":"Frank","year":"2016"},{"key":"10.1016\/j.phrs.2020.105095_bib0175","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2020.105095_bib0180","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1128\/JCM.40.4.1210-1213.2002","article-title":"Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients","volume":"40","author":"Liu","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.phrs.2020.105095_bib0185","article-title":"Rapid detection of four non-fermenting Gram-negative bacteria directly from cystic fibrosis patient\u2019s respiratory samples on the BD MAX system","volume":"12","author":"Rocchetti","year":"2018","journal-title":"Pract Lab Med"},{"key":"10.1016\/j.phrs.2020.105095_bib0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2180-10-245","article-title":"Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients","volume":"10","author":"Deschaght","year":"2010","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.phrs.2020.105095_bib0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12903-015-0071-1","article-title":"Development of a polymerase chain reaction assay for the rapid detection of the oral pathogenic bacterium, Selenomonas noxia","volume":"15","author":"Cruz","year":"2015","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.phrs.2020.105095_bib0200","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2020.105095_bib0205","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1021\/es502615e","article-title":"High throughput profiling of antibiotic resistance genes in urban park soils with reclaimed water irrigation","volume":"48","author":"Wang","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.phrs.2020.105095_bib0210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcf.2012.08.005","article-title":"Epidemiology and resistance of achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data","volume":"12","author":"Amoureux","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.phrs.2020.105095_bib0215","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1128\/AAC.04260-14","article-title":"Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans","volume":"59","author":"Hu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phrs.2020.105095_bib0220","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00019-11","article-title":"Stenotrophomonas maltophilia: an emerging global opportunistic pathogen","volume":"25","author":"Brooke","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.phrs.2020.105095_bib0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.arbres.2009.05.005","article-title":"Ralstonia pickettii in chronic obstructive pulmonary disease exacerbation","volume":"46","author":"Sancho-Chust","year":"2010","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.phrs.2020.105095_bib0230","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2147\/COPD.S173759","article-title":"Pseudomonas aeruginosa infection increases the readmission rate of COPD patients","volume":"13","author":"Choi","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.phrs.2020.105095_bib0235","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/mi.2016.108","article-title":"The respiratory tract microbiome and lung inflammation: a two-way street","volume":"10","author":"Huffnagle","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.phrs.2020.105095_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180859","article-title":"Influence of lung CT changes in chronic obstructive pulmonary disease (COPD) on the human lung microbiome","volume":"12","author":"Engel","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2020.105095_bib0245","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.watres.2017.05.065","article-title":"Degradation of highly consumed fluoroquinolones, penicillins and cephalosporins in distilled water and simulated hospital wastewater by UV254 and UV254\/persulfate processes","volume":"122","author":"Serna-Galvis","year":"2017","journal-title":"Water Res."},{"key":"10.1016\/j.phrs.2020.105095_bib0250","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2217\/fmb-2019-0002","article-title":"Roles of two-component regulatory systems in antibiotic resistance","volume":"14","author":"Tierney","year":"2019","journal-title":"Future Microbiol."},{"key":"10.1016\/j.phrs.2020.105095_bib0255","first-page":"152","article-title":"Biophysical and enzymatic properties of aminoglycoside adenylyltransferase AadA6 from Pseudomonas aeruginosa","volume":"4","author":"Papadovasilaki","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.phrs.2020.105095_bib0260","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1128\/AAC.01072-08","article-title":"MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor","volume":"52","author":"Fraud","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phrs.2020.105095_bib0265","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/thx.2005.045930","article-title":"Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis","volume":"61","author":"Wilson","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.phrs.2020.105095_bib0270","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1378\/chest.124.2.459","article-title":"Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD","volume":"124","author":"Groenewegen","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2020.105095_bib0275","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.01.17509280","article-title":"Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group","volume":"17","author":"Miravitlles","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.phrs.2020.105095_bib0280","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1378\/chest.06-1500","article-title":"Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy","volume":"131","author":"Stolz","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.phrs.2020.105095_bib0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7326\/ACPJC-2007-146-3-057","article-title":"Procalcitonin level-guided treatment reduced antibiotic use in exacerbations of COPD","volume":"146","author":"Niewoehner","year":"2007","journal-title":"ACP J. Club"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820314031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820314031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:17:06Z","timestamp":1760912226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820314031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":57,"alternative-id":["S1043661820314031"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105095","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105095"}}